BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18980943)

  • 1. Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice.
    ter Veld F; Primassin S; Hoffmann L; Mayatepek E; Spiekerkoetter U
    J Lipid Res; 2009 Aug; 50(8):1556-62. PubMed ID: 18980943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.
    Primassin S; Tucci S; Herebian D; Seibt A; Hoffmann L; ter Veld F; Spiekerkoetter U
    J Inherit Metab Dis; 2010 Jun; 33(3):237-46. PubMed ID: 20446112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
    Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
    Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
    Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
    Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
    Primassin S; Tucci S; Spiekerkoetter U
    Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
    Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
    PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term dietary effects on substrate selection and muscle fiber type in very-long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
    Tucci S; Pearson S; Herebian D; Spiekerkoetter U
    Biochim Biophys Acta; 2013 Apr; 1832(4):509-16. PubMed ID: 23313579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine supplementation induces long-chain acylcarnitine production--studies in the VLCAD-deficient mouse.
    Liebig M; Gyenes M; Brauers G; Ruiter JP; Wendel U; Mayatepek E; Strauss AW; Wanders RJ; Spiekerkoetter U
    J Inherit Metab Dis; 2006; 29(2-3):343-4. PubMed ID: 16763898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
    Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
    J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.
    Keeler AM; Conlon T; Walter G; Zeng H; Shaffer SA; Dungtao F; Erger K; Cossette T; Tang Q; Mueller C; Flotte TR
    Mol Ther; 2012 Jun; 20(6):1131-8. PubMed ID: 22395529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
    Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
    J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
    Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
    J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency.
    Zieger M; Keeler AM; Flotte TR; ElMallah MK
    J Inherit Metab Dis; 2019 Sep; 42(5):870-877. PubMed ID: 30993714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
    Tucci S; Behringer S; Spiekerkoetter U
    FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
    Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
    Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice.
    Bakermans AJ; van Weeghel M; Denis S; Nicolay K; Prompers JJ; Houten SM
    J Inherit Metab Dis; 2013 Nov; 36(6):973-81. PubMed ID: 23563854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.